The Case for Quality of Life Assessment in Glaucoma Clinical Trials

  • P. R. Lichter
  • M. H. Becker
  • N. K. Janz
Conference paper

Abstract

The pros and cons of medical or surgical therapy are commonly compared by assessing the risks and benefits of each therapeutic approach. This concept emphasizes that physicians and patients need to consider that every form of therapeutic intervention, while undertaken to make things better, could, in fact, in some ways make them worse. Ophthalmologists discuss the risk/benefit concept when, for example, they discuss cataract surgery with their patients. The patient weighs the potential benefits of improved vision (and improved quality of life) against the risks of surgical complications which could make their vision (and quality of life) worse.

Keywords

Sugar Burning Filtration Argon Diarrhea 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aaronson NK (1988) Quality of life: what is it? How should it be measured? Oncology 2:69–76PubMedGoogle Scholar
  2. Anderson GM, Lomas J (1988) Monitoring the diffusion of a technology: coronary artery bypass surgery in Ontario. Am J Public Health 78:251–254PubMedCrossRefGoogle Scholar
  3. Bergner M (1989) Quality of life, health status, and clinical research. Med Care 27 (3 Suppl): S148–S156PubMedCrossRefGoogle Scholar
  4. Bernth-Peterson P (1982) Outcome of cataract surgery. IV. socio-economic aspects. Acta Ophthalmol 60:461–468Google Scholar
  5. Churchill DN, Torrance GW, Taylor DW et al (1987) Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med 10:14–20PubMedGoogle Scholar
  6. Croog SH, Levine S, Testa MA et al (1986) The effects of antihypertensive therapy on the quality of life. N Engl J Med 314:1657–1664PubMedCrossRefGoogle Scholar
  7. Drummond MF (1988) Economic aspects of cataract. Ophthalmology 95:1147–1153PubMedGoogle Scholar
  8. Edmonds D, Vetter H, Vetter W (1987) Angiotension converting enzyme inhibitors in the clinic: quality of life. J Hypertension 5 (Suppl 3): S31-S35CrossRefGoogle Scholar
  9. Ferrell BR, Wisdom C, Wenzl C (1989) Quality of life an an outcome variable in the management of cancer pain. Cancer 63 (1): 2321–2327PubMedCrossRefGoogle Scholar
  10. Fletcher AE, Hunt BM, Bilpitt CJ (1987) Evaluation of quality of life in clinical trials of cardiovascular disease. J Chronic Dis 40:557–566PubMedCrossRefGoogle Scholar
  11. Hollenberg NK (1987) Initial therapy in hypertension: quality of life considerations. J Hypertension 5 (Suppl 1): S3-S7Google Scholar
  12. Kaplan RM, Anderson JP, Wu AW, Mathews WC, Kozin F, Orentstein D (1989) Medical Care 27 (3 Suppl):S27-S43PubMedCrossRefGoogle Scholar
  13. Kass MA, Gordon M, Meltzer DW (1986) Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? Am J Ophthalmol 101:524–530PubMedGoogle Scholar
  14. Kass MA, Gordon M, Morley RE et al (1987) Am J Ophthalmol 103:188–193PubMedGoogle Scholar
  15. Kass MA, Meltzer DW, Gordon M et al (1986) Compliance with topical pilocarpine treatment. Am J Ophthalmol 101:515–523PubMedGoogle Scholar
  16. Kutner NG (1987) Issues in the application of high cost medical technology: the case of organ transplantation. J Health Soc Behav 28:23–26PubMedCrossRefGoogle Scholar
  17. Levine S (1987) The changing terrains in medical sociology: emergent concern with quality of life. J Health Soc Behav 28:1–6PubMedCrossRefGoogle Scholar
  18. Nettleman MD (1989) Outcome measurements in decision analysis: Life versus quality of life. Infect Control Hops Epidemiol 10 (11): 521–524CrossRefGoogle Scholar
  19. O’Young J, McPeek B (1987) Quality of life variables in surgical trials. J Chronic Dis 40:513–522PubMedCrossRefGoogle Scholar
  20. Pearlman RA, Uhlmann RF (1988) Quality of life in chronic diseases: perceptions of elderly patients. J Gerontol 43 (2): M25-M30PubMedGoogle Scholar
  21. Peyrot M, McMurry JF, Jr (1985) Psychosocial factors in diabetic control: adjustment in insulin-treated adults. Psychosom Med 47:542–557PubMedGoogle Scholar
  22. Shipper H, Clinch J, McMurray A, Levitt M (1984) Measuring the qualify of life of cancer patients: the functional living index — cancer. J Clin Oncol 2:472–483Google Scholar
  23. Swales JD (1987) ACE inhibitors and the quality of life. J Cardiovasc Pharmacol 9 (Suppl 3): S22–S25PubMedCrossRefGoogle Scholar
  24. Tandon PK, Stander H, Schwarz RP (1989) Analysis of quality of life data from a randomized, placebo-controlled heart-failure trial. J Clin Epidemiol 42 (10): 955–962PubMedCrossRefGoogle Scholar
  25. Tarlov AR, Ware JE, Jr, Greenfield S, Nelson EC, Perrin E, Zubkoff M (1989) The medical outcomes study. An application of methods for monitoring the results of medical care. JAMA 262 (7): 925–930PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • P. R. Lichter
    • 1
  • M. H. Becker
    • 1
  • N. K. Janz
    • 1
  1. 1.Ann ArborUSA

Personalised recommendations